Defence Therapeutics appoints Ryan Simms as COO, radiopharmaceutical programs head

Reuters2026/08/17 07:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Defence Therapeutics named Ryan Simms as chief operating officer, adding oversight of its radiopharmaceutical programs.
Simms previously led chemistry, radiochemistry, clinical manufacturing, and external partnerships at Fusion Pharmaceuticals across multiple clinical-stage programs.
He also held leadership roles at Abdera Therapeutics and CPDC, focusing on CMC strategy, manufacturing, isotope supply, radiochemistry, and operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Defence Therapeutics Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608170315NEWSFILECNPR____20260817_309710_1) on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Defence Therapeutics appoints Ryan Simms as COO, radiopharmaceutical programs head

You may also like

Crypto prices